Anbio Biotechnology Ltd (NNNN): Market Cap to Revenue Ratio

Corporate company logo of Anbio Corp (NNNN)

Anbio Biotechnology is recognized as a global expert in the development of precision diagnostic systems. This P/S chart illustrates the market valuation of the business, where 17.30 represents the latest level. Market capitalization relies on the sales of portable analyzers and reagents. The company is currently overcoming a decline in demand for COVID tests by redirecting resources toward the production of general clinical laboratory tests.

Anbio - NNNN P/S Multiple (period 02/20/2025 - 11/13/2026)

Anbio Tech (NNNN) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Stock Price anbio.com|NNNN - Price Target Chart
- stock exchange capitalization data:
Market Capitalization Anbio Tech|NNNN - Enterprise Value
- business book valuation details:
Net Assets per Single Share Anbio Biotechnology|NNNN - Book Capitalization|Market Capitalization to Book Value anbio.com|NNNN - Aggregate Company Assets
- debt obligations and liquidity statistics:
Debt to Capital Anbio Biotechnology|NNNN - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Anbio Corp|NNNN - Company Aggregate Debts|Debt to Book Capitalization Ratio Anbio Tech|NNNN - Company Long-Term Debts|Short-Term Debt Volume Anbio Biotechnology|Immediate Liquidity anbio.com
- financial results and valuation multiples details:
NNNN - Net Income|Future Net Profit Anbio Biotechnology|NNNN - P/E Multiple|Projected Price to Earnings Ratio Anbio Biotechnology Ltd|NNNN - PEG Multiple|Enterprise Value to EBITDA Ratio Anbio Tech|NNNN - Operating profit EBITDA|Earnings per share for the trailing year Anbio Biotechnology|NNNN - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months anbio.com|NNNN - Earnings per share growth in current year|Expected net earnings per share growth next year Anbio Biotechnology
- issuer revenue and sales details:
NNNN - Company Revenue|Company Projected Revenue anbio.com|NNNN - Price-to-Revenue Ratio|Market Cap to Future Revenue Ratio Anbio Tech
General company analysis:anbio.com NNNN
Mass-produced product of Anbio Corp

Anbio Biotechnology generates stable income based on the sale of consumables for installed diagnostic equipment, making revenue a predictable value driver. The ratio of market capitalization to the volume of these sales determines the business's monetization efficiency, allowing the median P/S to assess the degree of overpayment for future operational cash flow growth and avoid capital losses during a trend reversal.

Competing companies

P/S Multiple agilent.com (A)|Price-to-Revenue Ratio Quest Diagnostics Incorporated DGX|ILMN: Market Cap to Revenue Ratio|Cologuard - P/S Multiple|RVTY: Price-to-Revenue Ratio|BIO: P/S Multiple|SHC - Price-to-Revenue Coefficient|Price-to-Revenue Ratio QuidelOrtho Corporation|Price to Sales OPKO Health Inc OPK|Market Cap to Revenue CDNA (CareDx Corp)|MRVI (Maravai) - Market Capitalization-to-Revenue Ratio|P/S Multiple FLGT (Fulgent Genetics, Inc.)|fluidigm.com - Price-to-Revenue Ratio|Cytek Biosciences - P/S Multiple|Price-to-Revenue Coefficient OraSure Technologies, Inc. OSUR|exagen.com (XGN) - Price-to-Revenue Ratio|Price to Sales MDxHealth, Inc. (MDXH)|Market Cap to Revenue LUCD|PRE (Prenetics Global Ltd) - Market Cap to Sales Volume|P/S Multiple IMDX|TRIB - Price to Sales|P/S Multiple PRPH (ProPhase)|AIMD - Market Cap to Revenue|Co-Diagnostics, Inc. - P/S Multiple|Market Capitalization-to-Revenue Ratio HSCS (heartsciences.com)|Biomerica (BMRA) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio CDIO|Price-to-Revenue Ratio Onconetix Corp|Price to Sales Virax Biolabs Corp VRAX|Price-to-Revenue Ratio Bluejay Diagnostics (BJDX)|Price-to-Revenue Ratio AWH (aspirawh.com)|Price-to-Revenue Ratio Accelerate Diagnostics, Inc. AXDX|Centogene N.V. (CNTG) - Price to Sales|Enzo - P/S Multiple|Price-to-Revenue Multiple Fresh2 Group Limited (FRES)|GENE (gtglabs.com) - Market Cap to Revenue|Price to Sales 23andme.com (ME)|Price-to-Revenue Ratio Psychemedics Corporation